Market Overview:
The global ethosuximide market is expected to register a CAGR of 5.5% during the forecast period (2018-2030). The growth in the market can be attributed to factors such as rising incidence of epilepsy, increasing awareness about the benefits of using ethosuximide and technological advancements in drug delivery systems. Based on type, the global ethosuximide market is segmented into capsules and solution. Capsules are further classified into immediate release capsules and extended release capsules. Solution is further classified into injectable solution and oral solution. Oral solutions are expected to dominate the global ethosuximide market during the forecast period owing to their ease of use and better patient compliance rates as compared to other formulations. Based on application, hospitals accounted for majority share of revenue generated by sales of ethosuximide products in 2017 followed by drug stores.
Product Definition:
Ethosuximide is a medication used to treat seizures. It is used to prevent tonic-clonic seizures and complex partial seizures.
Capsules:
Capsules are small vesicular structures made up of gelatin, paraffin or other materials. They contain the drug and a number of fillers that help in delivering it to the target organ. The drug is released gradually over an extended period in the body allowing it to attain maximum effect. Capsules also offer protection from stomach acids which further enhances its efficacy resulting in increased demand by patients suffering from Gastro-Esophageal Reflux (GER).
Solution:
Solution is a colorless, water-soluble, crystalline compound. It has a molecular weight of 132 and its solubility in water is 10?g/100 mL. The solution can be prepared by the general method for the synthesis of oxazolidinediones from 2-oxopropionic acid and ethyl (or propyl) amine.
Application Insights:
Hospital application was the largest segment in 2017 and accounted for a market share of over 80% in terms of revenue. The product is used to treat patients with Gullain-Barr¢â‚¬â„¢s syndrome, diabetic ketoacidosis, urea cycle disorders and rheumatoid arthritis. Growing prevalence of these chronic diseases is anticipated to boost the demand for ethosuximide during the forecast period.
Drug store application segment is expected to witness significant growth over the forecast period owing to rising awareness regarding diabetes among individuals aged 30 years and above along with increasing incidences of drug-resistant epilepsy among children which requires hospitalization due to refractory seizures. In addition, growing incidence of diabetic retinopathy as well as glaucoma will drive demand for treatment which requires usage of constant dosage throughout a longer duration leading towards higher consumption in drug stores over hospitals during future years.
Regional Analysis:
North America accounted for the largest share of ethosuximide market in 2017. The region is expected to maintain its dominance over the forecast period owing to increasing product utilization in epilepsy and other neurological disorders. In addition, growing awareness regarding new pharmaceutical products and rising healthcare expenditure are also contributing towards market growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising disposable income, improving healthcare infrastructure, expanding patient pool & awareness about available treatment options among others. Growing demand for generic drugs due to low cost coupled with easy availability of raw materials such as ethosuximide will further drive regional market growth during the estimated time span from 2018-2030 (see Figure 1).
Growth Factors:
- Increasing incidence of epilepsy: The global prevalence of epilepsy is estimated to be around 50 million, and the number of people with the disorder is increasing every year. This will create a large pool of patients who will require treatment, thereby driving the demand for ethosuximide.
- Rising awareness about available treatments: Epilepsy is a highly prevalent neurological disorder that can cause serious health complications if left untreated. However, there are now many effective treatment options available, which has led to an increase in awareness about the condition among patients and healthcare professionals alike. This is likely to drive uptake of ethosuximide in the coming years.
- Growing research on new uses for ethosuximide: Although originally developed as a treatment for epilepsy, researchers are now investigating potential new applications for ethosuximide in other conditions such as migraine headaches and bipolar disorder. This could lead to an increase in its use over time, boosting growth prospects for the market overall.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ethosuximide Market Research Report
By Type
Capsules, Solution
By Application
Hospital, Drug Store
By Companies
Akorn, Bionpharma, Heritage Pharms, Parke Davis, Puracap Pharm, Strides Pharma, Banner Pharmacaps, Convenant Pharma, Mikart, Teva Pharmaceuticals, Lambert, Pharmaceutical Associates（PAI）
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Ethosuximide Market Report Segments:
The global Ethosuximide market is segmented on the basis of:
Types
Capsules, Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Akorn
- Bionpharma
- Heritage Pharms
- Parke Davis
- Puracap Pharm
- Strides Pharma
- Banner Pharmacaps
- Convenant Pharma
- Mikart
- Teva Pharmaceuticals
- Lambert
- Pharmaceutical Associates（PAI）
Highlights of The Ethosuximide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsules
- Solution
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ethosuximide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ethosuximide is a medication used to treat seizures in adults and children. It works by blocking the action of certain chemicals in the brain that can cause seizures.
Some of the major companies in the ethosuximide market are Akorn, Bionpharma, Heritage Pharms, Parke Davis, Puracap Pharm, Strides Pharma, Banner Pharmacaps, Convenant Pharma, Mikart, Teva Pharmaceuticals, Lambert, Pharmaceutical Associates（PAI）.
The ethosuximide market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ethosuximide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ethosuximide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ethosuximide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ethosuximide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ethosuximide Market Size & Forecast, 2018-2028
4.5.1 Ethosuximide Market Size and Y-o-Y Growth
4.5.2 Ethosuximide Market Absolute $ Opportunity
Chapter 5 Global Ethosuximide Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ethosuximide Market Size Forecast by Type
5.2.1 Capsules
5.2.2 Solution
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ethosuximide Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ethosuximide Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ethosuximide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ethosuximide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ethosuximide Analysis and Forecast
9.1 Introduction
9.2 North America Ethosuximide Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ethosuximide Market Size Forecast by Type
9.6.1 Capsules
9.6.2 Solution
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ethosuximide Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ethosuximide Analysis and Forecast
10.1 Introduction
10.2 Europe Ethosuximide Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ethosuximide Market Size Forecast by Type
10.6.1 Capsules
10.6.2 Solution
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ethosuximide Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ethosuximide Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ethosuximide Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ethosuximide Market Size Forecast by Type
11.6.1 Capsules
11.6.2 Solution
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ethosuximide Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ethosuximide Analysis and Forecast
12.1 Introduction
12.2 Latin America Ethosuximide Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ethosuximide Market Size Forecast by Type
12.6.1 Capsules
12.6.2 Solution
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ethosuximide Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ethosuximide Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ethosuximide Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ethosuximide Market Size Forecast by Type
13.6.1 Capsules
13.6.2 Solution
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ethosuximide Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ethosuximide Market: Competitive Dashboard
14.2 Global Ethosuximide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Akorn
14.3.2 Bionpharma
14.3.3 Heritage Pharms
14.3.4 Parke Davis
14.3.5 Puracap Pharm
14.3.6 Strides Pharma
14.3.7 Banner Pharmacaps
14.3.8 Convenant Pharma
14.3.9 Mikart
14.3.10 Teva Pharmaceuticals
14.3.11 Lambert
14.3.12 Pharmaceutical Associates（PAI）
